In the following chapters, the manner in which three distinct EV-ncRNAs species modulate the PD-1/PD-L1 pathway across various tumor types through unique molecular mechanisms, ultimately resulting in phenotypic outcomes such as tumor growth, immune evasion, or suppression of tumor advancement, will be elaborated upon. This evidence concerns the gene PDCD1 and neoplasm.